The Artificial Heart Market is focused on the development and deployment of implantable mechanical circulatory support systems, primarily the Total Artificial Heart ($\text{TAH}$), which are used as a bridge to transplantation (BTT) for patients with end-stage biventricular heart failure. A $\text{TAH}$ replaces both native ventricles and valves, providing hemodynamic support when a ventricular...